| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.22▼ | 1.23▼ | 1.23▼ | 1.22▲ | 1.16▲ |
| MA10 | 1.23▼ | 1.23▼ | 1.23▼ | 1.19▲ | 1.23▼ |
| MA20 | 1.23▼ | 1.23▼ | 1.23▼ | 1.16▲ | 1.35▼ |
| MA50 | 1.23▼ | 1.21▲ | 1.19▲ | 1.24▼ | 1.75▼ |
| MA100 | 1.21▲ | 1.17▲ | 1.16▲ | 1.36▼ | 2.76▼ |
| MA200 | 1.18▲ | 1.15▲ | 1.20▲ | 1.71▼ | 8.31▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.003▼ | -0.003▼ | 0.018▲ | 0.011▲ |
| RSI | 44.207▼ | 48.523▼ | 50.592▲ | 55.343▲ | 41.149▼ |
| STOCH | 11.111▼ | 30.000 | 36.667 | 79.459 | 27.004 |
| WILL %R | -100.000▼ | -80.000▼ | -80.000▼ | -29.684 | -68.889 |
| CCI | -72.414 | -68.127 | -53.030 | 139.466▲ | -36.789 |
|
Thursday, March 12, 2026 07:06 AM
By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Important Readouts in 2026 for Phase 3 CTCL Study Soligenix, Inc. (NASDAQ:SNGX) is currently conducting the Phase 3 ...
|
|
Thursday, February 26, 2026 06:55 AM
(RTTNews) - Soligenix Inc. (SNGX) on Thursday said that the European Medicines Agency's Committee for Orphan Medicinal Products has issued a positive recommendation on the company's request for orphan ...
|
|
Thursday, August 21, 2025 01:25 AM
Sonoma Pharmaceuticals Inc. (NASDAQ:SNOA), Evoke Pharma Inc. (NASDAQ:EVOK), KALA BIO Inc. (NASDAQ:KALA), Ginkgo Bioworks Holdings Inc. (NYSE:DNA), and Soligenix Inc ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/03/26 | 1.23 | 1.2891 | 1.21 | 1.23 | 173,482 |
| 12/03/26 | 1.23 | 1.27 | 1.2002 | 1.22 | 133,601 |
| 11/03/26 | 1.21 | 1.26 | 1.20 | 1.23 | 142,851 |
| 10/03/26 | 1.17 | 1.245 | 1.16 | 1.23 | 326,121 |
| 09/03/26 | 1.19 | 1.2098 | 1.17 | 1.20 | 90,572 |
| 06/03/26 | 1.15 | 1.19 | 1.1207 | 1.19 | 92,947 |
| 05/03/26 | 1.17 | 1.185 | 1.12 | 1.15 | 115,301 |
| 04/03/26 | 1.13 | 1.18 | 1.11 | 1.17 | 91,566 |
| 03/03/26 | 1.12 | 1.1458 | 1.09 | 1.14 | 94,923 |
| 02/03/26 | 1.1537 | 1.176 | 1.13 | 1.17 | 97,640 |
|
|
||||
|
|
||||
|
|